Phase I/II Study of DFP-10917 in Combination With Venetoclax in Relapsed or Refractory Acute Myeloid Leukemia
Conditions: Leukemia, Myeloid, Acute Interventions: Drug: DFP-10917; Drug: Venetoclax Sponsors: Delta-Fly Pharma, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 24, 2024 Category: Research Source Type: clinical trials
Role of Antifungal Prophylaxis in Elderly Patients With Acute Myeloid Leukemia During Consolidation Therapy
Conditions: Invasive Aspergillosis Sponsors: University of Rome Tor Vergata Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 24, 2024 Category: Research Source Type: clinical trials
Maintenance Therapy of HMA in Favorable Risk AML Patients
Conditions: Acute Myeloid Leukemia Interventions: Drug: Hypomethylating agent, Azacitidine or Decitabine Sponsors: The First Affiliated Hospital of Soochow University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 23, 2024 Category: Research Source Type: clinical trials
Investigating the Role of Energy Balance Modification on Health Responses in Chronic Lymphocytic Leukaemia
Conditions: Chronic Lymphocytic Leukemia; Frailty; Muscle Function; Immune Function; Lipid Cell; Tumor Interventions: Behavioral: HIT; Behavioral: EXE+ Nutritional Guidance Sponsors: University of Surrey; American Society of Hematology Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 23, 2024 Category: Research Source Type: clinical trials
Maintenance Therapy of Hypomethylating Agent (HMA) in Favorable Risk Acute Myeloid Leukemia (AML) Patients
Conditions: Acute Myeloid Leukemia Interventions: Drug: Hypomethylating agent, Azacitidine or Decitabine Sponsors: The First Affiliated Hospital of Soochow University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 23, 2024 Category: Research Source Type: clinical trials
A Study of GLB-001 in Patients With Myeloid Malignancies
Conditions: Polycythemia Vera; Essential Thrombocythemia; Myelofibrosis; Myelodysplastic Syndromes; Acute Myeloid Leukemia; Myeloid Malignancy Interventions: Drug: GLB-001 Sponsors: Hangzhou GluBio Pharmaceutical Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 22, 2024 Category: Research Source Type: clinical trials
OBServatory of Compassionate Use of IVOsidenib in France for Patients With Acute Myeloid Leukemia
Conditions: AML, Adult Sponsors: French Innovative Leukemia Organisation; Acute Leukemia French Association Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 22, 2024 Category: Research Source Type: clinical trials
ICP-248 in Combination With Orelabrutinib in Treatment-na ïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Conditions: Hematologic Malignancies Interventions: Drug: ICP-248; Drug: Orelabrutinib Sponsors: Beijing InnoCare Pharma Tech Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 22, 2024 Category: Research Source Type: clinical trials
Feasibility of a Whole-Food, Plant-Based Diet for Patients With Low-Risk Chronic Lymphocytic Leukemia (CLL)
Conditions: Chronic Lymphocytic Leukemia Stage A(0) Interventions: Other: Whole-food, plant-based diet Sponsors: University of California, San Diego Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 22, 2024 Category: Research Source Type: clinical trials
Ziftomenib in Combination With Chemotherapy for Children With Relapsed/Refractory Acute Leukemia
Conditions: Relapsed/Refractory KMT2A-r Acute Leukemia; Relapsed/Refractory NUP98-r Acute Leukemia; Relapsed/Refractory NPM1-m Acute Leukemia Interventions: Drug: Ziftomenib; Drug: Cytarabine; Drug: Fludarabine Sponsors: LLS PedAL Initiative, LLC; Kura Oncology Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 19, 2024 Category: Research Source Type: clinical trials
A Study to Investigate APL-4098 Alone and/or in Combination With Azacitidine in R/R AML and High-Risk MDS
Conditions: Acute Myeloid Leukemia Refractory; Myelodysplastic Syndrome Acute Myeloid Leukemia; Myelodysplastic Syndrome With Excess Blasts; Acute Myeloid Leukemia, in Relapse Interventions: Drug: APL-4098; Drug: Azacitidine and APL-4098 Sponsors: Apollo Therapeutics Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2024 Category: Research Source Type: clinical trials
BiVictriX Announces FDA Orphan Drug Designation and Completion of FDA INTERACT Meeting for BVX001 in the Treatment of Acute Myeloid Leukemia
Alderley Park, 17 April 2024– BiVictriX Therapeutics plc (AIM: BVX), a biotechnology company developing novel, next-generation bispecific Antibody Drug Conjugates (bxADCs) which are designed to offer substantially improved cancer cell... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - April 17, 2024 Category: Pharmaceuticals Source Type: clinical trials
CD155 Expression in Acute Myeloid Leukemia
Conditions: Acute Myeloid Leukemia Interventions: Diagnostic Test: Flow cytometric immunophenotyping; Diagnostic Test: Complete blood count; Diagnostic Test: Bone marrow aspiration; Diagnostic Test: Cytogenetic testing; Diagnostic Test: FLT3-ITD using High resolution melting curve (HRM) analysis Sponsors: Assiut University Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
Oral Azacitidine in Transplant-Eligible Patients With Acute Myeloid Leukemia (AML) Suffering From Health-Inequality
Conditions: Acute Myeloid Leukemia Interventions: Drug: Oral Azacitidine Sponsors: Virginia Commonwealth University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
Pharmacokinetics of Dexamethasone in Childhood ALL and Reduction in Bone Mineral Density
Conditions: Acute Lymphoblastic Leukemia Sponsors: University of Aarhus Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 16, 2024 Category: Research Source Type: clinical trials
